Using a random-effects model, the pooled analysis yielded a mean difference of − 18.07 ng/mL (95% CI: − 40.14, 4.00, p = 0.11), indicating that circulating α-Klotho levels were generally lower in individuals with cognitive impairment, though the result did not reach statistical significance.
← all excerpts
Circulating α-Klotho and Multidimensional Aging and Frailty Outcomes: A Systematic Review and Meta-Analysis from the European Renal Association CKD-MBD Working Group.
1
—
—